Stereotactic Ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocol.

Biniam KidaneIan J GerardJonathan SpicerJulian O KimPierre O FisetPaul WawrykoMatthew J CecchiniRichard InculetBassam AbdulkarimDalilah FortinMehdi QiabiGefei QingStephanie EnnsBashir BashirJames TankelElliot WakeamAndrew WarnerNeil KopekBrian P YaremkoGeorge B RodriguesJoanna M LabaMelody QuRichard A MalthanerDavid A Palma

Published in: Cancer (2023)

The SABR-BRIDGE approach allowed for delivery of treatment during a period of operating room closure and was well-tolerated. Even in the best-case scenario, pCR rate does not exceed 82%.

Keyphrases

early stage
locally advanced
randomized controlled trial
combination therapy
brain metastases
replacement therapy
rectal cancer